Pain during and after coronavirus disease 2019: Chinese perspectives
Feng Jiang1, Wan-Li Yang1, Jia-Wei Wang2
1Translational Institute for Cancer Pain, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Chongming Branch, Shanghai, China.
Insights
The COVID-19 pandemic disrupted pain management, affecting both acute and chronic pain patients. Optimizing pain treatment during and after coronavirus disease 2019 is crucial for patient recovery and well-being.
Area of Science:
- Pain Medicine
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic has significantly impacted healthcare systems globally.
- Urgent public health measures have limited patient access to essential pain management services.
- Many COVID-19 patients experience acute painful symptoms, and some develop persistent pain sequelae.
Purpose of the Study:
- To discuss the challenges in diagnosing and treating chronic pain during the COVID-19 pandemic.
- To highlight the potential negative effects of pre-existing chronic pain in COVID-19 patients.
- To emphasize the need for optimized pain management strategies during and after COVID-19.
Main Methods:
- This review synthesizes early experiences from China in managing COVID-19 symptoms.
- It analyzes the impact of pandemic control measures on chronic pain care.
- Literature review on pain management in the context of COVID-19.
Main Results:
- COVID-19 prevention and control measures have created significant barriers to adequate pain treatment.
- Neurological symptoms, including pain, are often overlooked in hospitalized COVID-19 patients.
- Pre-existing chronic pain may be exacerbated or complicated by COVID-19 infection.
Conclusions:
- There is an urgent need to integrate comprehensive pain management into COVID-19 care protocols.
- Healthcare systems must adapt to ensure continuity of care for chronic pain patients amidst the pandemic.
- Optimizing pain management is essential for improving patient outcomes and quality of life during and after COVID-19.
Abstract:
The coronavirus disease 2019 (COVID-19) global pandemic poses a major threat to human health and health care systems. Urgent prevention and control measures have obstructed patients' access to pain treatment, and many patients with pain have been unable to receive adequate and timely medical services. Many patients with COVID-19 report painful symptoms including headache, muscle pain, and chest pain during the initial phase of the disease. Persistent pain sequela in patients with COVID-19 has a physical or mental impact and may also affect the immune, endocrine, and other systems. However, the management and treatment of neurological symptoms such as pain are often neglected for patients hospitalized with COVID-19. Based on the China's early experience in the management of COVID-19 symptoms, the possible negative effects of pre-existing chronic pain in patients with COVID-19 and the challenges of COVID-19 prevention and control bring to the diagnosis and treatment of chronic pain are discussed. This review calls to attention the need to optimize pain management during and after COVID-19.
More Related Videos
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:30Coronary Artery Disease III: Clinical Manifestations
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:29Pneumonia II: Pathophysiology